Hammerlindl H - Search Results

1

Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance.

Benfield AH, Vernen F, Young RSE, Nadal-Bufí F, Lamb H, Hammerlindl H, Craik DJ, Schaider H, Lawrence N, Blanksby SJ, Henriques ST. Benfield AH, et al. Among authors: hammerlindl h. Pharmacol Res. 2024 Sep;207:107298. doi: 10.1016/j.phrs.2024.107298. Epub 2024 Jul 18. Pharmacol Res. 2024. PMID: 39032840 Free article.

2

Small molecule in situ resin capture provides a compound first approach to natural product discovery.

Bogdanov A, Salib MN, Chase AB, Hammerlindl H, Muskat MN, Luedtke S, da Silva EB, O'Donoghue AJ, Wu LF, Altschuler SJ, Molinski TF, Jensen PR. Bogdanov A, et al. Among authors: hammerlindl h. Nat Commun. 2024 Jun 19;15(1):5230. doi: 10.1038/s41467-024-49367-x. Nat Commun. 2024. PMID: 38898025 Free PMC article.

3

H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase.

Ravindran Menon D, Hammerlindl H, Gimenez G, Hammerlindl S, Zuegner E, Torrano J, Bordag N, Emran AA, Giam M, Denil S, Pavelka N, Tan AC, Sturm RA, Haass NK, Rancati G, Herlyn M, Magnes C, Eccles MR, Fujita M, Schaider H. Ravindran Menon D, et al. Among authors: hammerlindl h. Drug Resist Updat. 2023 Nov;71:100993. doi: 10.1016/j.drup.2023.100993. Epub 2023 Aug 10. Drug Resist Updat. 2023. PMID: 37639774 Free PMC article.

4

Small Molecule in situ Resin Capture - A Compound First Approach to Natural Product Discovery.

Bogdanov A, Salib MN, Chase AB, Hammerlindl H, Muskat MN, Luedtke S, Barbosa da Silva E, O'Donoghue AJ, Wu LF, Altschuler SJ, Molinski TF, Jensen PR. Bogdanov A, et al. Among authors: hammerlindl h. bioRxiv [Preprint]. 2023 May 30:2023.03.02.530684. doi: 10.1101/2023.03.02.530684. bioRxiv. 2023. Update in: Nat Commun. 2024 Jun 19;15(1):5230. doi: 10.1038/s41467-024-49367-x PMID: 37398257 Free PMC article. Updated. Preprint.

5

Implantation of engineered adipocytes that outcompete tumors for resources suppresses cancer progression.

Nguyen HP, Sheng R, Murray E, Ito Y, Bruck M, Biellak C, An K, Lynce F, Dillon DA, Magbanua MJM, Huppert LA, Hammerlindl H, Esserman L, Rosenbluth JM, Ahituv N. Nguyen HP, et al. Among authors: hammerlindl h. bioRxiv [Preprint]. 2023 Mar 29:2023.03.28.534564. doi: 10.1101/2023.03.28.534564. bioRxiv. 2023. PMID: 37034710 Free PMC article. Preprint.

6

Modulating environmental signals to reveal mechanisms and vulnerabilities of cancer persisters.

Sun X, Bieber JM, Hammerlindl H, Chalkley RJ, Li KH, Burlingame AL, Jacobson MP, Wu LF, Altschuler SJ. Sun X, et al. Among authors: hammerlindl h. Sci Adv. 2022 Jan 28;8(4):eabi7711. doi: 10.1126/sciadv.abi7711. Epub 2022 Jan 28. Sci Adv. 2022. PMID: 35089788 Free PMC article.

7

Differential toxicity to murine small and large intestinal epithelium induced by oncology drugs.

Bieber JM, Sanman LE, Sun X, Hammerlindl H, Bao F, Roth MA, Koleske ML, Huang L, Aweeka F, Wu LF, Altschuler SJ. Bieber JM, et al. Among authors: hammerlindl h. Commun Biol. 2022 Jan 27;5(1):99. doi: 10.1038/s42003-022-03048-x. Commun Biol. 2022. PMID: 35087225 Free PMC article.

8

Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.

Ravindran Menon D, Hammerlindl H, Torrano J, Schaider H, Fujita M. Ravindran Menon D, et al. Among authors: hammerlindl h. Theranostics. 2020 May 15;10(14):6261-6277. doi: 10.7150/thno.42523. eCollection 2020. Theranostics. 2020. PMID: 32483452 Free PMC article. Review.

9

Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer.

Emran AA, Marzese DM, Menon DR, Hammerlindl H, Ahmed F, Richtig E, Duijf P, Hoon DS, Schaider H. Emran AA, et al. Among authors: hammerlindl h. Epigenomics. 2019 May;11(7):732-737. doi: 10.2217/epi-2018-0173. Epub 2019 May 9. Epigenomics. 2019. PMID: 31070054 Free PMC article.

10

Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.

Torrano J, Al Emran A, Hammerlindl H, Schaider H. Torrano J, et al. Among authors: hammerlindl h. Clin Epigenetics. 2019 Mar 8;11(1):43. doi: 10.1186/s13148-019-0644-y. Clin Epigenetics. 2019. PMID: 30850015 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters